Gaudium IVF and Women Health Limited (NSE:GAUDIUMIVF)

Market Cap	5.89B
Revenue (ttm)	707.24M +1,045.3%
Net Income	191.27M +21,484.2%
EPS	3.12 +21,536.9%
Shares Out	72.79M
PE Ratio	25.99
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	330,262
Average Volume	1,381,164
Open	82.49
Previous Close	80.87
Day's Range	78.40 - 83.00
52-Week Range	72.02 - 87.15
Beta	n/a
RSI	n/a
Earnings Date	Mar 18, 2026

About NSE:GAUDIUMIVF

Gaudium IVF and Women Health Limited provides in vitro fertilization (IVF) treatment in India. The company offers fertility and reproductive health services, including intracytoplasmic sperm injection (ICSI), intrauterine insemination (IUI), and ovulation induction; polycystic ovarian syndrome (PCOS)/ polycystic ovarian disease (PCOD); endometriosis treatment; ovulation induction; and laser assisted embryo implantation services. It also provides male infertility treatment services; infertility surgeries; egg freezing; surrogacy; and laparoscopi...

• Industry: Specialty Outpatient Facilities, Not Elsewhere Classified
• Founded: 2009
• Employees: 117
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: GAUDIUMIVF

Financial Performance

In fiscal year 2025, NSE:GAUDIUMIVF's revenue was 707.24 million, an increase of 47.68% compared to the previous year's 478.90 million. Earnings were 191.27 million, an increase of 85.40%.